Closing The Books On GDUFA II: How Generics Fared At US FDA Over The Last Five Years

 
• By Derrick Gingery
  
generic drugs bottle
About 16% of ANDA approvals in FY 2022 were first-time generic drugs. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Generics

More from Biosimilars & Generics